US 8507206
Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)
granted A61PA61P25/28
Quick answer
US patent 8507206 (Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)) held by Acumen Pharmaceuticals, Inc. expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acumen Pharmaceuticals, Inc.
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P25/28